3187 results for «864»
3187 results
An intrepid solution for transfemoral treatment of mitral regurgitation
21 Nov 2023 – From PCR London Valves 2023
In this session, get insights into the APOLLO EU trial and its current progress, obtain a comprehensive understanding of the latest data from the Early Feasibility TF trial, and discern which patients stand to benefit the most from this treatment.
Best contemporary clinical practice for TAVI
21 Nov 2023 – From PCR London Valves 2023
Watch this session if you wish to explore emerging trends for transcatheter aortic valve implantation in younger patients, the specific considerations for TAVI in individuals with an extended life expectancy, and examine how valve design and implantation techniques can impact long-term outcomes.
Finishing strong - Latest best practices and technologies for large hole arterial and venous closure
21 Nov 2023 – From PCR London Valves 2023
Consult this session to grasp the current landscape of techniques for closing large holes in both arterial and venous contexts. Acquire valuable tips and tricks aimed at minimizing vascular complications, and learn about the innovative patch-based closure approach for a comprehensive understanding.
Addressing remaining issues after TAVI: what to expect from the new generation?
21 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to discuss the challenges of TAVI for lower-risk patients, and to capture the features of new TAVI devices.
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
Controversies in atrioventricular valves - The Heart Team ring, Vol II
19 Nov 2023 – From PCR London Valves 2023
This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Participate in discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
Essentials of lifetime management of TAVI patients
21 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to learn about the next generation transcatheter heart valve technology key features, procedural and clinical benefits, to learn tips and tricks for managing bicuspid and valve-in-valve interventions, and to understand procedural and clinical relevance of intermediate and XL sizes in...
TAVI failure - Mechanisms and management
19 Nov 2023 – From PCR London Valves 2023
Explore various cases that focus on TAVI failure, including the effects of the mechanism of TAVR failure on outcomes after re-intervention, the prognostic impact of patient-prosthesis mismatch and paravalvular leak following TAVI, issues related to bioprosthetic valve dysfunction and much more!
Tricuspid transcatheter valve replacement: Cardiovalve keeps things in motion
20 Nov 2023 – From PCR London Valves 2023
Participate in this session to stay informed about the latest advancements in TTVR, receive updates on the Cardiovalve tricuspid program, and gain insights into how imaging demonstrates the concept underlying Cardiovalve transcatheter valve replacement technology.
TAVI in complex scenarios
19 Nov 2023 – From PCR London Valves 2023
What do we mean by "complex scenarios"? When zero-contrast TAVI implantation becomes a good alternative in kidney disease, when TAVI is implanted in a patient with mechanical mitral valve, or when TAVI is implanted in very large annulus with subannular aneurysm, for example!
TAVI - Coronary protection strategies
20 Nov 2023 – From PCR London Valves 2023
Consult this session for key insights into diverse coronary protection approaches: get a look at the management of a complex case involving a degenerated aortic bioprosthesis and paravalvular leak, observe a successful TAVI in calcified bicuspid anatomy with low coronaries, delve into a case featuring a degenerated...
Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices
20 Nov 2023 – From PCR London Valves 2023
Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...
Complex tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Consult this session to discover a selection of abstracts regarding tricuspid valve procedures: explore the complexities of long-term right heart remodeling after transcatheter tricuspid annuloplasty, witness the journey from pre-clinical studies to the first-in-man experience with MonarQ tricuspid valve replacement, delve into Tripair, an innovative transcatheter spacer...
New devices for tricuspid valve intervention
20 Nov 2023 – From PCR London Valves 2023
Join this session for a quick overview of groundbreaking devices shaping tricuspid valve interventions: witness the first-in-man experience with a cross-caval device designed for the treatment of tricuspid regurgitation, navigate through a challenging case involving a patient with massive tricuspid regurgitation and a permanent pacemaker lead and...
Mitral TEER - Part 1
20 Nov 2023 – From PCR London Valves 2023
Gain valuable insights into Mitral Transcatheter Edge-to-Edge Repair (TEER) with this session: explore the prognostic impact of post-procedural mitral regurgitation and gradient after TEER for primary mitral regurgitation and delve into the evolving landscape of same-day discharge following transcatheter edge-to-edge repair.
TAVI - complications
21 Nov 2023 – From PCR London Valves 2023
Because TAVI is not without risk, learn about bailout endovascular techniques to counter transcatheter aortic valve LV dislocation, analyze the cost of infectious complications caused by TAVR compared with SAVR, and discover how imaging can predict aortic root rupture or conduction abnormalities, among others.
Valve in valve - TAV in TAV - Part 2
21 Nov 2023 – From PCR London Valves 2023
Join us for this session, where complex cases shed light on the evolving landscape of valve-in-valve interventions: delve into the efficacy of THV-in-THV for addressing supra-skirtal leakage accompanied by intravascular hemolysis, learn more about the challenges of TAVI-in-TAVI with the deployment of SAPIEN3 Ultra in a...
